482 F.Supp.3d 80
S.D.N.Y.2020Background
- Plaintiff Shivan Bassaw (Bronx resident) bought Hot Shot Concentrated Deep Reach Fogger in August 2016, relying on label claims that it “kills on contact,” “controls heavy infestations,” “keeps killing for up to 2 months,” and “kills hidden bugs.”
- Bassaw alleges the product did not work as advertised and that he and a putative class overpaid for an ineffective product.
- Claims: nationwide unjust enrichment and breach of express warranty (and MMWA claim derivative of warranty), and a New York subclass claim under NY Gen. Bus. Law §§ 349 and 350 for deceptive practices/false advertising.
- Procedural: Bassaw sent a notice letter to defendants on August 9, 2019 (nearly three years after purchase) and filed suit; defendants moved to dismiss for lack of Article III standing, lack of personal jurisdiction over non‑NY class members, failure to give timely warranty notice, and insufficiency of NYGBL claims.
- The Court denied standing and the personal‑jurisdiction challenge as to the named plaintiff, dismissed the express warranty and MMWA claims for untimely notice (and dismissed unjust enrichment and injunctive relief as abandoned), and allowed the NYGBL §349/350 claims to proceed.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Article III standing (injury‑in‑fact) | Bassaw paid for Hot Shot and received a product that failed to perform; that is a concrete economic injury. | No cognizable injury; Plaintiff suffered no concrete harm. | Standing satisfied: alleged "paid too much/received too little" economic injury is concrete and particularized. |
| Personal jurisdiction over out‑of‑state class members | Class action in federal court; jurisdictional issues for non‑resident members can await class certification. | Bristol‑Myers bars jurisdiction over nonresident claims where contacts are lacking. | Denied as to Rule 12(b)(2): Court has jurisdiction over the named plaintiff; deferred any ruling on non‑NY class members until class certification. |
| Express warranty & MMWA (timeliness/notice) | Plaintiff provided notice in Aug. 2019; may assert discovery rule or retail‑purchaser exceptions. | Under N.Y. U.C.C. § 2‑607(3)(a) buyer must notify within a reasonable time after discovering breach; notice here was unreasonably delayed. | Dismissed: notice given nearly three years after purchase is unreasonable as a matter of law; warranty and MMWA claims dismissed; leave to amend denied. |
| NYGBL §§ 349/350 (deceptive conduct and false advertising) | Label statements were consumer‑oriented, materially misleading, and caused plaintiffs to overpay; reliance is not an element of statutory claim. | Section 350 fails for lack of reasonable reliance; independent sources could have revealed truth. | Survived: consumer‑oriented and materially misleading allegations sufficient; reliance not required by statute, and any reliance reasonableness is a fact issue. |
Key Cases Cited
- Spokeo, Inc. v. Robins, 136 S. Ct. 1540 (2016) (Article III requires concrete, particularized injury)
- Bristol‑Myers Squibb Co. v. Superior Court, 137 S. Ct. 1773 (2017) (limits on specific jurisdiction for out‑of‑state plaintiffs)
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (2007) (plausibility standard for Rule 12(b)(6))
- Ashcroft v. Iqbal, 556 U.S. 662 (2009) (apply plausibility and draw reasonable inferences for pleadings)
- Orlander v. Staples, Inc., 802 F.3d 289 (2d Cir. 2015) (elements of NYGBL §§ 349/350 claims)
- Goshen v. Mutual Life Ins. Co. of N.Y., 774 N.E.2d 1190 (N.Y. 2002) (false advertising standard under § 350 parallels § 349)